Resumes
Resumes
Aneel Aggarwal Phones & Addresses
-
156 Panorama Dr, Edgewater, NJ 07020 (201) 969-1225
-
New York, NY
-
Cambridge, MA
-
Somerville, MA
-
156 Panorama Dr, Edgewater, NJ 07020 (201) 248-4658
Work
Position:
Machine Operators, Assemblers, and Inspectors Occupations
Education
Degree:
High school graduate or higher
Publications
Us Patents
Za Loops Of Bromodomains
View pageUS Patent:
7919276, Apr 5, 2011
Filed:
Feb 22, 2000
Appl. No.:
09/510314
Inventors:
Ming-Ming Zhou - Greenwich CT, US
Aneel K. Aggarwal - Edgewater NJ, US
Aneel K. Aggarwal - Edgewater NJ, US
Assignee:
Mount Sinai School of Medicine - New York NY
International Classification:
C12P 19/34
US Classification:
435 911
Abstract:
The present invention provides the structural determination of a bromodomain determined by NMR spectroscopy. The present invention also provides a binding partner for the bromodomain. In addition, the present invention provides methodology for related drug discovery using high throughput drug screening or structure based rational drug design using the three-dimensional data.
Methods Of Identifying Modulators Of Bromodomains
View pageUS Patent:
20040009613, Jan 15, 2004
Filed:
Jul 31, 2002
Appl. No.:
10/209201
Inventors:
Ming-Ming Zhou - Greenwich CT, US
Aneel Aggarwal - Edgewater NJ, US
Eric Verdin - San Francisco CA, US
Melanie Ott - San Francisco CA, US
Aneel Aggarwal - Edgewater NJ, US
Eric Verdin - San Francisco CA, US
Melanie Ott - San Francisco CA, US
International Classification:
G06F019/00
G01N033/48
G01N033/50
G01N033/543
G01N033/48
G01N033/50
G01N033/543
US Classification:
436/518000, 702/019000
Abstract:
The present invention provides the structural determination of a bromodomain determined by NMR spectroscopy. The present invention also provides binding partners for the bromodomain. The present invention further provides the structural determination of the Tat-P/CAF binding complex determined by NMR spectroscopy. In addition, the present invention provides methodology for related drug discovery using high throughput drug screening or structure based rational drug design using the three-dimensional data.
Methods Of Identifying Modulators Of Bromodomains
View pageUS Patent:
20040043378, Mar 4, 2004
Filed:
Feb 16, 2001
Appl. No.:
09/784553
Inventors:
Ming-Ming Zhou - Greenwich CT, US
Aneel Aggarwal - Edgewater NJ, US
Eric Verdin - San Francisco CA, US
Melanie Ott - San Francisco CA, US
Aneel Aggarwal - Edgewater NJ, US
Eric Verdin - San Francisco CA, US
Melanie Ott - San Francisco CA, US
International Classification:
C12Q001/70
C07H021/04
A61K039/42
C07K014/16
C12P021/02
C12N005/06
C07H021/04
A61K039/42
C07K014/16
C12P021/02
C12N005/06
US Classification:
435/005000, 435/069300, 435/320100, 435/325000, 530/350000, 536/023720, 424/160100
Abstract:
The present invention provides the structural determination of a bromodomain determined by NMR spectroscopy. The present invention also provides binding partners for the bromodomain. The present invention further provides the structural determination of the Tat-P/CAF binding complex determined by NMR spectroscopy. In addition, the present invention provides methodology for related drug discovery using high throughput drug screening or structure based rational drug design using the three-dimensional data.
Methods Of Modulating Bromodomains
View pageUS Patent:
20120028912, Feb 2, 2012
Filed:
Nov 2, 2009
Appl. No.:
12/590069
Inventors:
Ming-Ming Zhou - Greenwich CT, US
Aneel K. Aggarwal - Edgewater NJ, US
Melanie Ott - San Francisco CA, US
Eric Verdin - San Francisco CA, US
Aneel K. Aggarwal - Edgewater NJ, US
Melanie Ott - San Francisco CA, US
Eric Verdin - San Francisco CA, US
International Classification:
A61K 38/10
A61K 31/135
A61P 31/18
A61K 31/16
A61K 31/352
A61K 38/08
A61K 31/195
A61K 31/135
A61P 31/18
A61K 31/16
A61K 31/352
A61K 38/08
A61K 31/195
US Classification:
514 215, 514 217, 514 216, 514649, 514564, 514651, 514630, 514457
Abstract:
The present invention features compounds useful for and methods for preventing or inhibiting the binding of bromodomains to acetyl-lysine residues of proteins and methods for treating HIV infection and HIV related disease.